In the slow, deliberate world of clinical innovation, the most critical connections are often the hardest to make. A founder with a novel diagnostic needs a physician-investor who understands the regulatory pathway. A digital health startup scaling needs an operator who has navigated hospital procurement before. Health Board Advisors, operating from Westwood, New York, is building a marketplace to formalize those matches, betting that a curated, physician-led network can accelerate ventures from seed to scale more reliably than a traditional accelerator’s spray-and-pray approach [Health Board Advisors].
Its core mechanism is a self-described "Triple-Match System," which aims to align clinical founders, embedded operators, and physician-led capital based on a shared fit in mission, clinical model, and mindset [Health Board Advisors]. The promise is specificity over volume, a rebuttal to the generic demo-day model. For a sector where a misaligned advisor can cost months and a disconnected investor can kill a round, the premise is intuitively compelling. The company claims this approach has driven a "90% follow-on funding rate across our portfolio," though it does not publicly name the portfolio companies or provide independently verifiable data to support the figure [Health Board Advisors, About HBA].
The clinical venture wedge
Health Board Advisors positions itself not as an accelerator but as a full "seed-to-scale clinical venture ecosystem" [Health Board Advisors]. This means its services are designed to persist beyond an initial program. The model combines several functions that are typically siloed.
- Clinical vetting and matching. The system is built to evaluate and connect physician-founders with physician-investors and operators who share their specific clinical domain and strategic vision [Health Board Advisors].
- Strategic operator support. Beyond capital, the platform aims to provide founders with access to embedded operators who offer hands-on guidance through growth and regulatory hurdles [Advisor Fellowship | Health Board Advisors].
- Capital facilitation. While HBA itself does not appear to have announced a fund, it facilitates connections to "physician-led capital," acting as a matchmaker between startups and investors with aligned healthcare thesis [HBA Investor Partner Preferences].
The ecosystem also includes public-facing initiatives like the HealthTech Impact Awards, which recognize early-stage founders in categories like digital health and diagnostics, offering media exposure and investor access [HealthTech Impact Awards, Pulsepointpath.com].
Traction through a curated network
Evidence of the company’s reach is piecemeal but points to active deal flow. A third-party funding tracker from 2026 lists Health Board Advisors as an investor in several healthcare startups, including Floreo, Ilant Health, Koda Health, and Photon Health [Fierce Healthcare, 2026]. This suggests the entity is participating in rounds, though the structure and size of its checks are not public. The company also maintains an invite-only advisor fellowship, suggesting a focus on building a high-quality, engaged network rather than an open marketplace [Advisor Fellowship].
Leadership includes co-founders identified as "Richie" and Val Alexandre Torres, who is listed as Co-Founder & COO on a LinkedIn profile [Health Board Advisors] [Marianela Paz Fuentealba Pincheira - Ayun LLC | LinkedIn]. The background of the founding team in healthcare operations and venture is referenced but not detailed in public materials, with one co-founder noted for having helped raise millions for founders [Advisor Fellowship | Health Board Advisors].
The crowded landscape of venture support
The company’s bet is that a physician-specific, fit-based model can carve out a defensible niche. The competitive set, however, is vast and well-funded. Generalist accelerators like Y Combinator and Techstars have massive networks and brand recognition, though they lack clinical specialization. Within healthcare, entities like Rock Health have established tracks for digital health. Health Board Advisors’ differentiation rests entirely on the quality and exclusivity of its clinical network and the efficacy of its matching algorithm,assets that are difficult to quantify from the outside.
The primary risk is one of liquidity and scale. A highly curated, invite-only model may ensure quality matches but could limit the volume of deals and the network’s overall growth. Furthermore, the 90% follow-on rate claim, while a powerful marketing tool, requires external validation to become a credible metric for founders choosing between support platforms. Success will be measured not by reported rates but by the eventual outcomes of its portfolio companies: regulatory clearances, commercial launches, and successful exits.
The standard of care for clinical founders
For a physician with an idea, the traditional path to venture scale is often fragmented and inefficient. It typically involves cobbling together a network through academic conferences, hoping for a warm introduction to a specialist investor, and hiring consultants to fill operational gaps. This ad-hoc process can delay development and dilute founder focus. Health Board Advisors is attempting to productize that chaotic journey, offering a structured, ongoing ecosystem intended to replace serendipity with systemization. The patient population, in this case, is the clinical founder themselves,often experts in medicine but navigating the unfamiliar terrain of venture financing and company building for the first time. The company’s thesis is that their outcomes improve when every connection is intentional.
Sources
- [Health Board Advisors] Health Board Advisors | Healthcare Vision & Funding | https://healthboardadvisors.com/
- [Health Board Advisors, About HBA] Healthcare Advisors Who Drive Growth & Better Care | https://healthboardadvisors.com/about-us/
- [Health Board Advisors, Advisor Fellowship] Advisor Fellowship | Health Board Advisors | https://healthboardadvisors.com/advisor-fellowship/
- [Health Board Advisors, HBA Investor Partner Preferences] HBA Investor Partner Preferences | https://investors.healthboardadvisors.com/
- [HealthTech Impact Awards, Pulsepointpath.com] HealthTech Impact Awards | https://pulsepointpath.com/awards
- [Fierce Healthcare, 2026] Funding Tracker '26: Ours Privacy, Arintra and Happy Health | https://www.fiercehealthcare.com/health-tech/fierce-healthcare-fundraising-tracker-26
- [LinkedIn] Marianela Paz Fuentealba Pincheira - Ayun LLC | LinkedIn | https://www.linkedin.com/in/marianela-fuentealba-p/